Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Eisai Co., Ltd.
  6. Company
    4523   JP3160400002

EISAI CO., LTD.

(4523)
  Report
Delayed Japan Exchange  -  01:00:00 2023-02-09 am EST
7569.00 JPY   -1.77%
02/07Eisai Records 35% Decline in Fiscal Nine-month Profit on Higher Operating Expenses
MT
02/06Lower Yen Raises Tokyo Stock Market
MT
02/06Jefferies Adjusts Eisai's Price Target to 8,000 Yen From 10,000 Yen, Keeps at Hold
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Eisai Co., Ltd.
Eisai Company specializes in the manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical products (87.7%): prescribed drugs, health products, etc.;

- other (12.3%): food additives, chemical products, etc.

Net sales are distributed geographically as follows: Japan (46.2%), Europe (19.5%), Americas (15.5%), China (10.3%) and other (8.4%).

Number of employees : 11 322 people.
Sales per Business
20212022Delta
Pharmaceutical586 060.0090.7%626 281.0082.8% +6.86%
Other59 881.009.3%129 945.0017.2% +117.01%
JPY in Million
Sales per region
20212022Delta
Japan263 520.0040.8%243 385.0032.2% -7.64%
Americas160 433.0024.8%226 719.0030% +41.32%
Europe87 562.0013.6%126 745.0016.8% +44.75%
China84 883.0013.1%106 592.0014.1% +25.58%
Other49 544.007.7%52 784.007% +6.54%
JPY in Million
Managers
Name Title Age Since
Haruo Naito Manager-Research & Development Promotions 75 1983
Tatsuyuki Yasuno Manager-Corporate Planning 54 2014
Keisuke Naito Executive Officer & Head-Global IT Headquarters 34 2022
Yasushi Okada Manager-Business Planning 64 2002
Yosuke Akita Chief Compliance Officer & & Head-Internal Control 57 2022
Gary Bryan Hendler President-EMEA Region 56 2012
Takashi Owa Chief Discovery Officer, Head-Japan & Asia Medical 59 2021
Ivan Cheung Manager-Promotions 46 2009
Terushige Iike Executive Officer & Manager-Corporate Strategy 59 2012
Masatomi Akana Chief Government Relations Officer 56 2020
Members of the board
Name Title Age Since
Yasuhiko Katoh Chairman 75 2018
Shuzo Kaihori Independent Outside Director 75 2018
Hideyo Uchiyama Independent Outside Director 69 2018
Yumiko Miwa Independent Outside Director 57 2020
Fumihiko Ike Independent Outside Director 70 2021
Ryota Miura Independent Outside Director 48 2021
Clive Richard Thornley Independent Outside Director 58 2022
Haruo Naito Manager-Research & Development Promotions 75 1983
Hideki Hayashi Manager-Business Development 65 2004
Yoshiteru Kato Executive Officer 62 2014
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0.01 296,566,949 276,655,602 93.3% 9,667,274 3.3% 93.3%
Shareholders
NameEquities%
Wellington Management Co. LLP 20,752,870 7.00%
Nomura Asset Management Co., Ltd. 17,294,899 5.83%
Government of Japan 14,945,200 5.04%
Sumitomo Mitsui Trust Asset Management Co., Ltd. 9,995,300 3.37%
Eisai Co., Ltd. 9,666,100 3.26%
Asset Management One Co., Ltd. 9,048,700 3.05%
Nippon Life Insurance Co. 9,030,000 3.04%
Nikko Asset Management Co., Ltd. 8,896,500 3.00%
Daiwa Asset Management Co. Ltd. 8,217,800 2.77%
The Vanguard Group, Inc. 6,985,606 2.36%
Holdings
NameEquities%Valuation
EISAI CO., LTD. (4523) 9,666,100 3.26% 637,642,459 USD
MATSUKIYOCOCOKARA & CO. (3088) 2,815,000 1.97% 140,808,665 USD
ALFRESA HOLDINGS CORPORATION (2784) 2,302,724 1.14% 29,249,799 USD
SUZUKEN CO., LTD. (9987) 1,040,945 1.18% 28,164,568 USD
COGSTATE LIMITED (CGS) 11,738,243 6.77% 15,602,120 USD
KISSEI PHARMACEUTICAL CO., LTD. (4547) 474,000 0.91% 9,268,406 USD
ROIVANT SCIENCES LTD. (ROIV) 874,957 0.12% 6,990,906 USD
VITAL KSK HOLDINGS, INC. (3151) 642,154 1.05% 4,136,807 USD
HOKUYAKU TAKEYAMA HOLDINGS,INC. (3055) 546,005 2.24% 2,487,708 USD
MEDIPAL HOLDINGS CORPORATION (7459) 129,395 0.053% 1,707,353 USD
Markets and indexes
- Prime
- Nikkei 225 /
Stock Exchange Codes
- Bloomberg Code :  4523:JP
- Reuters Code :  4523.T
- Datastream Code :  
Company contact information
Eisai Co., Ltd.
4-6-10 Koishikawa
JP-112-8088 Bunkyo-ku, Tokyo

Phone : +81 3 3817 3700
Fax :
web site : https://www.eisai.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Eisai Co., Ltd.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
EISAI CO., LTD.-11.48%16 815
JOHNSON & JOHNSON-7.38%427 207
ELI LILLY AND COMPANY-7.15%322 756
NOVO NORDISK A/S3.00%313 215
MERCK & CO., INC.-3.88%267 941
ABBVIE INC.-10.52%256 590
ROCHE HOLDING AG-2.07%251 191
PFIZER, INC.-14.93%244 684
ASTRAZENECA PLC-4.15%197 019
NOVARTIS AG-5.13%181 983
BRISTOL-MYERS SQUIBB COMPANY3.57%165 408
AMGEN INC.-8.54%130 193
SANOFI-2.84%116 456
GILEAD SCIENCES, INC.-0.21%107 304
GSK PLC4.41%71 986
BAYER AG29.31%61 940
DAIICHI SANKYO CO., LTD.-4.24%59 405
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.73%49 494
CHUGAI PHARMACEUTICAL CO., LTD1.72%42 907
JIANGSU HENGRUI MEDICINE CO., LTD.11.50%39 539
ASTELLAS PHARMA INC.-4.61%26 382